Significance of HER2/neu overexpression in pure ductal carcinoma in situ: A clinicopathologic study with long-term follow-up.

被引：1
|
作者：
Al-Mansour, Zeina [1 ]
Stockl, Thomas [1 ]
Khan, Ashraf [1 ]
Horner, Richard [1 ]
Cosar, Ediz [1 ]
Hsieh, Chung-Cheng [1 ]
Kandil, Dina [1 ]
机构：
[1] Univ Massachusetts, Sch Med, Worcester, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 26期
关键词：
D O I：
10.1200/jco.2013.31.26_suppl.85
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
85
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Significance of HER-2/neu Overexpression in Ductal Carcinoma In Situ: A Clinicopathologic Study With Long-Term Follow-up
    Stockl, Thomas
    Khan, Ashraf
    Horner, Richard
    Al-Mansour, Zeina
    Cosar, Ediz
    Hsieh, Chung-Cheng
    Kandil, Dina
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 : A152 - A152
  • [2] The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast
    Latta, EK
    Tjan, S
    Parkes, RK
    O'Malley, FP
    MODERN PATHOLOGY, 2002, 15 (12) : 1318 - 1325
  • [3] The relevance of occult axillary micrometastasis in ductal carcinoma in situ - A clinicopathologic study with long-term follow-up
    Lara, JF
    Young, SM
    Velilla, RE
    Santoro, EJ
    Templeton, SF
    CANCER, 2003, 98 (10) : 2105 - 2113
  • [4] Elucidation of frequent HER2 overexpression in ductal carcinoma in situ
    Horimoto, Y.
    Terao, T.
    Tsutsumi, Y.
    Tanabe, M.
    Mogushi, K.
    Arakawa, A.
    Sonoue, H.
    Saito, M.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S131 - S132
  • [5] The Significance of HER2 Protein Overexpression in Ductal Carcinoma In Situ of Breast: A Single Institutional Experience
    Leivo, Mariah
    Fadare, Oluwole
    Hasteh, Farnaz
    Zare, Somaye
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 196 - 197
  • [6] The Significance of HER2 Protein Overexpression in Ductal Carcinoma In Situ of Breast: A Single Institutional Experience
    Leivo, Mariah
    Fadare, Oluwole
    Hasteh, Farnaz
    Zare, Somaye
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 196 - 197
  • [7] Significance of HER2 Protein Examination in Ductal Carcinoma In Situ
    Horimoto, Yoshiya
    Tokuda, Emi
    Arakawa, Atsushi
    Kosaka, Taijiro
    Saito, Mitsue
    Kasumi, Fujio
    JOURNAL OF SURGICAL RESEARCH, 2011, 167 (02) : E205 - E210
  • [8] HER2/neu overexpression in estrogen receptor-positive ductal carcinoma in situ: prevalence and phenotype.
    Livasy, C. A.
    Perou, C. M.
    Carey, L. A.
    Cowan, D.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S75 - S76
  • [9] The evaluation of the immunoexpression of Her2/neu oncoprotein in ductal carcinoma in situ in association with invasive ductal carcinoma of the breast
    Fota, Georgiana Luminita
    Stepan, A.
    Ciurea, Raluca Niculina
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2012, 53 (03): : 805 - 810
  • [10] Prognostic Significance of HER-2/neu Expression in Patients with Ductal Carcinoma In Situ
    Stackievicz, Rodica
    Paran, Haim
    Bernheim, Joelle
    Shapira, Mayra
    Weisenberg, Neomy
    Kaufman, Tzvi
    Klein, Ehud
    Gutman, Mordechai
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2010, 12 (05): : 290 - 295
12345